Adipogenesis and insulin sensitivity in obesity are regulated by retinoid-related orphan receptor gamma

Bettina Meissburger1, Jozef Ukropec, Eva Roeder

  • 1ETH Zürich, Institute of Food Nutrition and Health, Schwerzenbach, Switzerland.

EMBO Molecular Medicine
|August 20, 2011
PubMed

Insights

Retinoid-related orphan receptor gamma (RORγ) negatively regulates fat cell development. Blocking RORγ improves insulin sensitivity and protects against obesity-related metabolic disorders like type 2 diabetes.

Area of Science:

  • Metabolic disease research
  • Molecular endocrinology
  • Adipocyte biology

Background:

  • Obesity is a major risk factor for metabolic complications, including type 2 diabetes.
  • However, not all obese individuals develop metabolic disorders, suggesting underlying regulatory mechanisms.
  • Identifying factors that control adipocyte function is crucial for understanding metabolic health.

Purpose of the Study:

  • To investigate the role of retinoid-related orphan receptor gamma (RORγ) in regulating adipocyte differentiation and function.
  • To determine if RORγ influences insulin sensitivity and metabolic health in obesity.
  • To explore RORγ as a potential therapeutic target for obesity-associated insulin resistance.

Main Methods:

  • Investigated RORγ's role in adipocyte differentiation using mouse models (Rorγ-deficient mice).
  • Analyzed adipocyte size, insulin sensitivity, and metabolic parameters (hyperglycemia, insulin resistance) in obese Rorγ(-/-) mice.
  • Examined RORγ expression in adipose tissue from obese human subjects and correlated it with adipocyte size and insulin sensitivity.

Main Results:

  • RORγ acts as a negative regulator of adipocyte differentiation, partly via its target gene matrix metalloproteinase 3.
  • Rorγ-deficient mice exhibited enhanced adipocyte progenitor cell differentiation and smaller adipocytes when obese.
  • Obese Rorγ(-/-) mice showed improved insulin sensitivity, better free fatty acid control, and protection against hyperglycemia and insulin resistance.
  • In humans, RORγ expression in adipose tissue correlated with adipocyte size and inversely with adipogenesis and insulin sensitivity.

Conclusions:

  • RORγ controls adipogenesis and adipocyte size, thereby modulating insulin sensitivity in obesity.
  • RORγ is identified as a key factor linking obesity to insulin resistance.
  • RORγ represents a promising novel pharmaceutical target for treating obesity-associated insulin resistance.

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...